1. Home
  2. MYGN vs ASTL Comparison

MYGN vs ASTL Comparison

Compare MYGN & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.60

Market Cap

399.9M

Sector

Health Care

ML Signal

HOLD

Logo Algoma Steel Group Inc.

ASTL

Algoma Steel Group Inc.

HOLD

Current Price

$4.56

Market Cap

467.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
ASTL
Founded
1991
1902
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
399.9M
467.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
MYGN
ASTL
Price
$4.60
$4.56
Analyst Decision
Hold
Analyst Count
9
0
Target Price
$8.06
N/A
AVG Volume (30 Days)
1.1M
1.5M
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
2.10%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$771,400,000.00
N/A
Revenue This Year
$7.26
N/A
Revenue Next Year
$5.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.33
N/A
52 Week Low
$3.76
$3.02
52 Week High
$11.44
$7.50

Technical Indicators

Market Signals
Indicator
MYGN
ASTL
Relative Strength Index (RSI) 37.54 49.34
Support Level $3.76 $4.21
Resistance Level $5.66 $4.64
Average True Range (ATR) 0.35 0.38
MACD 0.06 -0.03
Stochastic Oscillator 32.61 26.03

Price Performance

Historical Comparison
MYGN
ASTL

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

Share on Social Networks: